Overview

GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
Purpose:The aim of this project is to prospectively determine whether a single dose of GnRH-agonist administered at the time of implantation increases or not the reproductive outcome in patients undergoing in vitro fertilization ( IVF)/ intracytoplasmatic sperm injection(ICSI) triggered by a GnRH-agonist followed by a small bolus of human chorionic gonadotropin (hCG 1500 IU) the day of oocyte retrieval.
Phase:
Phase 3
Details
Lead Sponsor:
Centre Hospitalier Universitaire Ibn Rochd
Treatments:
Deslorelin
Triptorelin Pamoate